The public record · 119th Congress

Medication Affordability and Patent Integrity Act

The Congressional Research Service has not published a summary of this measure.

Other titles

the names this measure carries besides the one at the top of this page, each with the record's own label for it. The collection includes titles given to parts of a bill as well as to the whole.

A bill to require sponsors of drug applications and holders of approved applications to provide certain submissions and communications to the Food and Drug Administration and the United States Patent and Trademark Office.Official Title as Introduced

Medication Affordability and Patent Integrity ActShort Title(s) as IntroducedShort Title(s) as Reported to Senate

Legislative history

S. 2658·Senate·Bill·Health

Sen. Maggie Hassan(Democratic-New Hampshire)·

Aug 1, 2025

SenateRead twice and referred to the Committee on Health, Education, Labor, and Pensions.

Mar 19, 2026

Senate · CommitteeCommittee on Health, Education, Labor, and Pensions. Hearings held.

Jun 17, 2026

Senate · CommitteeCommittee on Health, Education, Labor, and Pensions. Ordered to be reported with an amendment in the nature of a substitute favorably.

Jul 28, 2026

Senate · CommitteeCommittee on Health, Education, Labor, and Pensions. Reported by Senator Cassidy with an amendment in the nature of a substitute. Without written report.

Jul 28, 2026

SenatePlaced on Senate Legislative Calendar under General Orders. Calendar No. 528.

Documents

Everything Congress printed about this measure. A bill is reprinted each time it changes, the Congressional Research Service summarizes each version, and the committee that reports a bill files its own written account of it.

Bill text

Jul 28, 2026As reported by the Senate committee Aug 1, 2025As introduced in the Senate